Evidence map›Paper›PMID 30195243›Full record

Trial reportDrug and alcohol dependence2018

Randomized controlled trial of a positive affect intervention for methamphetamine users.

Adam W Carrico, Walter Gόmez, Jennifer Jain, Steven Shoptaw, Michael V Discepola, David Olem, Justin Lagana-Jackson, Rick Andrews, Torsten B Neilands, Samantha E Dilworth and 3 more

2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 38 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 3 pooled it
7.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01926184 nacompletednot on this map

Randomized Controlled Trial of an Integrative Intervention for Non-Treatment-Seeking Meth Users

TypeinterventionalSponsorUniversity of California, San FranciscoRan2013 to 2018Enrolled110ConditionsHIV/AIDS, Stimulant Use DisordersArmsAffect Regulation Treatment to Enhance Meth Intervention Success (ARTEMIS), Contingency Management (CM)
NCT07281378 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Reducing Co-occurring Substance Use and HIV Risk Among Stimulant-using Men at High Risk for HIV in the United States of America.

TypeinterventionalSponsorUniversity of FloridaRan2026 to 2027Enrolled84ConditionsDrug Use Disorders, PrEP Uptake, PrEP Adherence, HIV Risk BehaviorArmsTailored Positive Affect Intervention, Contingency Management
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 3 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Psychosocial interventions for stimulant use disorder.The Cochrane database of systematic reviews · 2024
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Neighborhood-level adversity and inflammation among sexual minority men living with HIV.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2025
    Article
  19. Collective efficacy: A protective factor for sexual minority men during the U.S. mpox outbreak.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Adam W CarricoDepartment of Public Health Sciences, University of Miami School of Medicine, 1120 NW 14th St., Office 1005, Miami, FL 33136 USA. Electronic address: a.carrico@miami.edu.
Walter GόmezBerkeley School of Social Welfare, University of California, 120 Haviland Hall, #7400, Berkeley, CA 94720 USA.
Jennifer JainDepartment of Medicine, Division of Global Public Health, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 902093 USA.
Steven ShoptawDepartments of Family Medicine and Psychiatry, David Geffen School of Medicine, University of California, Los Angeles, 10080 Wilshire Blvd., Los Angeles, CA 900024 USA.
Michael V DiscepolaSan Francisco AIDS Foundation, 1035 Market Street, Suite 400, San Francisco, CA 94103 USA.
David OlemUniversity of California, San Francisco School of Medicine, Box 0886, 550 16th Street, 3469, San Francisco, CA 94158 USA.
Justin Lagana-JacksonUniversity of California, San Francisco School of Medicine, Box 0886, 550 16th Street, 3469, San Francisco, CA 94158 USA.
Rick AndrewsSan Francisco AIDS Foundation, 1035 Market Street, Suite 400, San Francisco, CA 94103 USA.
Torsten B NeilandsUniversity of California, San Francisco School of Medicine, Box 0886, 550 16th Street, 3469, San Francisco, CA 94158 USA.
Samantha E DilworthUniversity of California, San Francisco School of Medicine, Box 0886, 550 16th Street, 3469, San Francisco, CA 94158 USA.
Jennifer L EvansUniversity of California, San Francisco School of Medicine, Box 0886, 550 16th Street, 3469, San Francisco, CA 94158 USA.
William J WoodsUniversity of California, San Francisco School of Medicine, Box 0886, 550 16th Street, 3469, San Francisco, CA 94158 USA.
Judith T MoskowitzDepartment of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, 633 N. Saint Clair St., 19th Floor, Chicago, IL 60611 USA.
University of California, San Francisco · USSan Francisco AIDS Foundation · USNorthwestern University · USUniversity of California, Berkeley · USUniversity of California, Los Angeles · USUniversity of California, San Diego · USUniversity of Miami · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Sung-Jae Lee · 1997 to 2026
$53.5M
Training Program in Substance Use, HIV and Related InfectionsT32DA023356 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Natasha Martin, Steffanie A Strathdee · 2007 to 2026
$7.8M
RCT of an integrative intervention for non-treatment-seeking meth usersR01DA033854 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CARRICO, ADAM WAYNE, MOSKOWITZ, JUDITH T. · 2013 to 2017
$2.8M
Positive Affect Regulation for HIV Prevention in People with Mood DisordersK24MH093225 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MOSKOWITZ, JUDITH T. · 2011 to 2015
$713k
NIAID NIH HHS P30 AI027763NIDA NIH HHS R01 DA033854NIDA NIH HHS T32 DA023356NIMH NIH HHS K24 MH093225NIMH NIH HHS P30 MH058107
6 · The paper itself

Abstract

backgroundContingency management (CM) is an evidence-based intervention providing rewards in exchange for biomarkers that confirm abstinence from stimulants such as methamphetamine. We tested the efficacy of a positive affect intervention designed to boost the effectiveness of CM with HIV-positive, methamphetamine-using sexual minority men.

methodsThis attention-matched, randomized controlled trial of a positive affect intervention delivered during CM was registered on www.clinicaltrials.gov (NCT01926184). In total, 110 HIV-positive sexual minority men with biologically confirmed, recent methamphetamine use were enrolled. Five individual sessions of a positive affect intervention (n = 55) or an attention-control condition (n = 55) were delivered during three months of CM. Secondary outcomes examined over the 3-month intervention period included: 1) psychological processes relevant to affect regulation (i.e., positive affect, negative affect, and mindfulness); 2) methamphetamine craving; 3) self-reported stimulant use (past 3 months); and 4) cumulative number of urine samples that were non-reactive for stimulants (i.e., methamphetamine and cocaine) during CM.

resultsThose randomized to the positive affect intervention reported significant increases in positive affect during individual sessions and increases in mindfulness over the 3-month intervention period. Intervention-related improvements in these psychological processes relevant to affect regulation were paralleled by concurrent decreases in methamphetamine craving and self-reported stimulant use over the 3-month intervention period.

conclusionsDelivering a positive affect intervention may improve affect regulation as well as reduce methamphetamine craving and stimulant use during CM with HIV-positive, methamphetamine-using sexual minority men.

Indexed as

MethamphetamineAdultAmphetamine-Related DisordersBehavior TherapyCentral Nervous System StimulantsEarly Intervention, EducationalFollow-Up StudiesHIV SeropositivityHomosexuality, MaleHumansMaleMiddle AgedMindfulnessRewardSexual and Gender MinoritiesCentral Nervous System StimulantsMethamphetamineContingency managementHIVMen who have sex with menMethamphetamineMindfulnessPositive affect

Identifiers

PMID30195243
PMCPMC6200638
OpenAlexW2890956924

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.